The global branded generics market is projected to increase from USD 414.5 billion in 2026 to USD 928.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 8.4%, according to Future Market Insights (FMI). The market is benefiting from sustained demand for affordable prescription medicines, particularly in chronic disease management, alongside physician familiarity with...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek